Gastroenterol Res
Gastroenterology Research, ISSN 1918-2805 print, 1918-2813 online, Open Access
Article copyright, the authors; Journal compilation copyright, Gastroenterol Res and Elmer Press Inc
Journal website http://www.gastrores.org

Original Article

Volume 10, Number 1, February 2017, pages 33-41


Prevalence of Helicobacter pylori Infection in Samples of Gastric Biopsies

Leda Maria Delmondes Freitas Trindadea, d, Lania Barreto de Oliveira Menezesa, Adozina Marques de Souza Netaa, Paulo Candido Leite Rolemberga, Lais Dantas Souzaa, Ikaro Daniel de Carvalho Barretob, Luise Meurerc

aDepartment of Medicine, Tiradentes University, Aracaju 49032-490, Brazil
bBiometrics and Applied Statistics - PPGBEA - UFRPE, Aracaju 49160-000, Brazil
cDepartment of Gastroenterology and Hepatology, Laboratory of Pathological Anatomy Dra. Monica Araujo (LAPMA), Aracaju 49015-230, Brazil
dCorresponding Author: Leda Maria Delmondes Freitas Trindade, Department of Medicine, Tiradentes University, 300 Murilo Dantas Ave., Aracaju 49032-490, Brazil

Manuscript accepted for publication February 06, 2017
Short title: Prevalence of H. pylori Infection
doi: https://doi.org/10.14740/gr785w

Abstract▴Top 

Background: Helicobacter pylori (H. pylori) infection affects about 50% of the world population and its association with environmental factors and host properties is involved in gastric carcinogenesis. The study aimed to estimate the prevalence of H. pylori in samples of gastric mucosa biopsies, correlate the presence of the bacteria in the sample with the variables age, sex and origin, to identify the types of lesions found in patients with H. pylori, and to evaluate the association of the lesions with the region of the gastric mucosa.

Methods: A cross-sectional, retrospective study was carried out in Aracaju, Sergipe, Brazil, from January 2013 to December 2015. A total of 45,206 gastric mucosal biopsies were obtained from patients submitted to upper gastrointestinal endoscopy. Of the reports evaluated, 12,909 met the inclusion criteria since they presented the patient’s demographic data as well as the histopathological characteristics of gastric mucosal regions and positivity for H. pylori. Data were analyzed by IBM SPSS Statistic 20 and subjected to descriptive analyses (categorical variables) and inferential (Pearson’s Qui-square and linear association tests) and multiple correspondence analyses. Significance level adopted 5%.

Results: Of the total of 12,909 (28.6%) reports evaluated, 67% (8,647) came from urban areas and 64.5% (8,320) were female. The mean age (standard deviation (SD)) was 43 years, ranging from 8 to 100 years, prevailing between 21 and 60 years. Among the types of gastric mucosa analyzed, 95.5% (12,322) were of the antral mucosa. The absence of glandular atrophy, the mild infection intensity for H. pylori, the absence of metaplasia, the presence of foveolar hyperplasia and lymphoid follicles were statistically significant (P < 0.001) in this region. In the fundic region, the evidence of fibrinoleucocytic crust and lymphoid follicles was significant (P < 0.001). There was no evidence of associated ulcerated lesions or significant relationship with intestinal metaplasia in the antral mucosa, whereas the fundic mucosa had a strong association with lymphoid follicles. The prevalence of active H. pylori infection in this study was 30.93%.

Conclusion: Detection rate of H. pylori and its association with acute and chronic inflammation should be taken into account. The antral region has shown higher incidence and the presence of H. pylori was strongly associated with foveolar hyperplasia and lymphoid follicles.

Keywords: Helicobacter pylori; Gastric mucosa; Prevalence of Helicobacter pylori; Atrophy; Intestinal metaplasia

Introduction▴Top 

For over 100 years, micro-organisms have been observed in the gastric tissue, and its association with gastritis has been known since the 1970s. In 1982, Marshall and Warren identified and cultivated Campylobacter pyloridis, later called Helicobacter pylori (H. pylori) [1].

H. pylori is a spiral-shaped gram-negative and microaerophilic [2]. Its ability to proliferate and survive in the gastric environment is due to factors such as the production of urease by the microorganism, its motility and ability to adhere to the gastric epithelium. The way through which the infection occurs remains unknown. However, person to person transmission appears to be the most likely one, either through fecal-oral or oral-oral exposure [3].

Conservative approaches to this issue suggest that 50% of the population is affected by H. pylori and it is considered the commonest bacterial infection in humans [4]. Genetic sequencing analysis suggests that humans have been infected with H. pylori since their first migration from Africa some 58,000 years ago [5]. Once acquired, the infection persists and may or may not produce gastroduodenal disease [3]. The prevalence of the infection varies according to age, socioeconomic status and ethnicity. Socioeconomic status is also an important determinant and inversely correlated to H. pylori infection [6]. Furthermore, within any age range, the infection appears to be more common amongst blacks and Hispanics compared to whites [7].

In developing countries, where most children are infected before the age of 10, the prevalence in adults reaches more than 80% before aged 50. In developed countries, like the United States, the evidence of the infection among children is very unlikely to happen, but it becomes more common during adulthood [7]. The increase in the prevalence of infection with age was initially thought to represent a continuous rate of acquisition of the bacterium throughout the life. However, new epidemiological evidence indicates that most infections are acquired during childhood, even in developed countries [7].

Recent studies [6] suggest that, in developing countries, such as Iran, hygiene practices in childhood and family education determine the prevalence of the infection. In Japan, from 1950 on, there was a rapid decline of the infection rate attributed to the economic progress of the post-war period and improved sanitation [8]. The quality of life and socioeconomic conditions should be considered risk factors to acquire H. pylori infection [9].

The chronic inflammation induced by H. pylori interferes with the normal physiology of the gastric acid secretion in different degrees, thus leading to chronic gastritis, which, in most individuals, remains asymptomatic and does not progress. However, in some cases, altered gastric secretion, associated with tissue injury, induces the development of peptic ulcer, whereas in other cases, gastritis progresses to atrophy, intestinal metaplasia, and eventually to gastric carcinoma or rarely to gastric lymphoma, due to the persistent immune stimulation of the lymphoid tissue [10].

The gastritis can be classified based on the severity of the mucosal lesion as erosive or non-erosive, according to the site of gastric involvement (cardia, body and antrum) and histologically, as acute or chronic based on the type of inflammatory cell. However, no classification scheme fits perfectly into pathophysiology, and the evolution of gastric atrophy involves different clinical and pathophysiological consequences. Gastric gland atrophy may be present in several lesions, especially gastritis, which can progress to the multifocal gastritis associated with the bacterium H. pylori and atrophic gastritis of the body, not dependent on the presence of the bacterium [11].

In view of the above, it is necessary to identify the prevalence with H. pillory infection, independently of associated lesions, in order to discuss these aspects with the purpose of contributing to their reduction. The study aimed to: 1) determine the prevalence of H. pylori in samples of gastric mucosa biopsies (antrum, body, cardia and fundus), obtained through upper digestive endoscopy and original reports of surgical pathology in a pathology laboratory Aracaju, Sergipe, Brazil; 2) correlate the presence of H. pylori in gastric biopsy material with the variables such as age, region (urban versus rural) and sex; 3) identify the types of lesions found in gastric mucosa with H. pylori positive; and 4) evaluate the association of the lesions found with the biopsied gastric mucosal region.

Methodology▴Top 

Between January 2013 and December 2015, a cross-sectional, retrospective study was performed at the Laboratory of Pathological Anatomy Dra. Monica Araujo (LAPMA), in Aracaju, Sergipe, based on the analysis of gastric mucosa reports obtained through biopsies of gastric mucosa from body, antrum, cardia and fundus, with H. pylori infection, regardless of whether through endoscopy and/or specimens of surgical resection. Reports from specimens of surgical resection were excluded because they presented incomplete information. During the research period, 45,206 biopsies were performed for the study of H. pylori from endoscopic gastric mucosa biopsy. Of this total, 13,986 reports were evaluated because they presented a positive result for the bacterium, and 1,077 were excluded because they did not meet the inclusion criteria, i.e., all reports should present the patients’ demographic data, histopathological characteristics of the biopsied regions of the gastric mucosa and positivity for H. pylori. The final sample consisted of 12,909 biopsy reports.

A questionnaire was used as a data collection tool to identify the anatomopathological profile of the mucosa, which consisted of a tab with multiple-choice and short-text questions, elaborated by the researchers, having as dependent variable, the existence of H. pylori and independent variables: the patients’ demographic characteristics (name, age, urban vs. rural region and sex); the histopathological characteristics of the antrum, fundus, cardia and body regions of the gastric mucosa such as the presence of chronic inflammation and inflammatory activity; glandular atrophy; intestinal metaplasia; evidence of ulcerated lesion; presence of fibrinoleukocytic crust, foveolar hyperplasia, lymphoid follicles, granulomas and other alterations, and the intensity of H. pylori colonization. The degree of intestinal metaplasia, classification of glandular atrophy and intensity of H. pylori colonization were performed according to the Sydney System [11]. The histological diagnosis of gastritis with and without H. pylori infection based on the Sydney System allowed to classify it histologically and to identify its topographic distribution from gastric biopsy.

As for the methodology used for the staining of the gastric biopsy fragments, for the histological examination, the fragments were deposited in bottles identified topographically, containing 10% formalin solution and led to a routine histological process, then subjected to 5 μm cuts and stained with hematoxylin-eosin and Giemsa.

To analyze the data, descriptive and inferential analyses were performed. In the descriptive ones, the categorical variables were presented by means of simple frequency and percentage, as for the continuous ones, through mean and standard deviation (SD). In the inferential analysis, Pearson’s Chi-square association and line tests were used. In order to evaluate the histopathological profile of the biopsied regions of the gastric mucosa, the perceptual map was constructed from the multiple correspondence analyses. The significance level adopted was 5% and the software used for the analysis was IBM SPSS Statistics 20.0. The study was approved by the Committee of Ethics and Research of the Universidade Tiradentes-CEP/UNIT (CAAE: 49195515.4.0000.5371).

Results▴Top 

Endoscopic gastric biopsies totaled a sample of 45,206 biopsies. Of the total sample, 13,986 were H. pylori positive, which translates into a prevalence of 30.93% (45,206). For data analysis, 12,909 reports met the inclusion criteria. Regarding sociodemographic variables, 8,320 (64.5%) of the samples were female and 4,589 (35.5%) were male. Of the samples, 8,647 (72.3%) were from urban areas. The mean age (SD) was 43 years (14.5%), and the age range of the sample varied from 8 to 100 years, being more prevalent between 21 and 60 years (Fig. 1).

Figure 1.
Click for large image
Figure 1. Age group of patients with positive H. pylori infection.

As for the prevalence of gastric mucosa types and levels of infection, the antral mucosa was stated to appear the most representative fragment, corresponding to 95.5% (12,322) of the samples. It was also observed that 45.4% (5,857) of them had mild infection and 43.3% (5,587) presented moderate infection levels (Table 1).

Table 1.
Click to view
Table 1. Prevalence of Gastric Mucosa Types Represented in the Study and Levels of H. pylori Infection
 

The lesions were characterized as: glandular atrophy, intestinal metaplasia (specialized glands of the gastric body are replaced by intestinal type cells), ulcerations (gastric and duodenal ulcers), fibrinoleucocytic crust, foveolar hyperplasia, lymphoid follicles, granulomas, in addition to chronic inflammation and evidence of inflammatory activity. The absence of glandular atrophy was observed in 93.2% (12,033) of the biopsies. The mild type level of angular atrophy appeared in 6.1% (793) of the samples. In this study, 89.5% (11,548) of the cases had no intestinal metaplasia. In the 10.5% of cases with intestinal metaplasia, focal type was the most frequent when compared to diffuse and multifocal metaplasia. Some of the histologic features examined in this study were shown in Figures 2 and 3.

Figure 2.
Click for large image
Figure 2. Histological section of gastric mucosa with H. pylori chronic gastritis. (A) Gastritis. (B) Inflammatory activity. (C) Oxyntic mucosal gastritis. (D) Lymphoid follicle (arrow) (H&E, × 100).

Figure 3.
Click for large image
Figure 3. Antral mucosa with intestinal metaplasia (H&E, × 100).

The presence of lymphoid follicles was more often observed compared to other alterations found (gastric and duodenal ulceration, fibrinoleucocytic crust, presence of foveolar hyperplasia and granulomas) (Table 2).

Table 2.
Click to view
Table 2. Histopathologic Findings of the Gastric Mucosa in Patients With Positive H. pylori Infection
 

Regarding the relationship between the inflammatory process and the biopsied regions of the gastric mucosa, in all the regions evaluated, there was predominance of moderate degree, both in chronic inflammation and in the presence of inflammatory activity (Table 3).

Table 3.
Click to view
Table 3. Correlation Between Inflammation and Biopsied Gastric Regions in Patients With Positive H. pylori Infection
 

Comparing the histopathological findings between the antrum and other regions of the stomach, the antral region has a higher rate (P < 0.001) of glandular atrophy, H. pylori infection level, presence of foveolar hyperplasia and lymphoid follicles (Table 4).

Table 4.
Click to view
Table 4. Correlation Between Histopathological Findings of Antral Region and Other Locations of the Gastric Mucosa in H. pylori Positive Patients
 

In the fundic region, an evidence of fibrinoleucocytic crust and lymphoid follicles were significant (P < 0.001) when compared to other regions of the gastric mucosa (Table 5).

Table 5.
Click to view
Table 5. Correlation Between Histopathological Findings of Fundus and Other Locations of the Gastric Mucosa in H. pylori Positive Patients
 

Through the multiple correspondence analyses, the anatomopathological profile of the antral and fundic mucosa was observed due to the proximity between the objects. In the antral mucosa, in addition to the presence of H. pylori degrees of mild to moderate, there was significant relationship with the absence of glandular atrophy, absence of associated ulcerated lesions and absence of intestinal metaplasia (Fig. 4).

Figure 4.
Click for large image
Figure 4. Pathological profile of the antral mucosa.

Fundic mucosa displayed a strong association with the lymphoid follicles, partially linked to the mild and moderate levels of H. pylori infection, partially associated with the absence of glandular atrophy and absence of foveolar hyperplasia (Fig. 5).

Figure 5.
Click for large image
Figure 5. Pathological profile of the fundic mucosa.
Discussion▴Top 

Evidence estimates that 50% of the world population is affected by H. pylori. It is considered the commonest bacterial infection in humans [12, 13]. The prevalence of infection varies from age to age, ethnicity and especially socioeconomic status which is an important determinant and inversely correlated with the infection [4, 6].

The present study displayed a H. pylori infection prevalence of 30.93%. Previous studies [14-16] ranged from 26.91% to 76% in prevalence putting the present study close to the lower range point. Although the literature points out that H. pylori serum-prevalence is equally distributed in men and women, in this study, females had a higher prevalence, and the mean age of the infected was 43 years [13, 17]. The predominant age group ranged from 21 to 60 years (83%), whereas in developed countries, such as the United States, serologic values ??of H. pylori are rarely found before the age of 10. Between the age of 18 and 30, these values reach 10% and increase to 50% in people over 60 [4]. In developing nations, where most children are infected before the age of 10, the prevalence in adults reaches more than 80% before the age of 50 [4]. In Brazil, Bedoya et al [18] made a comparison with several diagnostic tests and reported a prevalence of 34% in children and young people up to 18 years old, increasing significantly over aging process.

Evaluating the level of intensity regarding the presence of H. pylori in the biopsied material, it was found that the mild and moderate levels predominated in all gastric regions. No studies supporting these findings could be found in literature.

The pathological profile of the gastric mucosa displayed presence of chronic inflammation and inflammatory activity in a moderated level in almost all biopsied regions, except for the region of the cardia, in relation to the inflammatory activity. According to Hagymasi et al [19], H. pylori-induced continuous inflammation, usually confined to the antrum, alters the physiology of gastric acid secretion to varying degrees, leading to chronic gastritis, which in most individuals does not further evolve.

Evidence points out that chronic gastritis induced by H. pylori affects the stomach’s antrum and body mucosa in most of the cases [20, 21]. A study conducted in Brazil by Alvares et al [22] identified a prevalence of 88.4% of chronic gastritis in H. pylori positive patients, with significantly more inflammation in the antrum and angular incisure than in the gastric body. In the present study, evidence of ulcerated lesions was found in 4.2% of the H. pylori positive samples evaluated. Antral and fundic regions presented similar results, with a prevalence of 4.3% and 4.2%, respectively.

Odze and Goldblum [23] stated that although H. pylori infects more than half of the world’s population, only 1-3% of the patients infected develop gastric adenocarcinoma. Therefore, a prevalence of glandular atrophy and intestinal metaplasia in the samples was evaluated. Glandular atrophy was absent in 93.2% of the H. pylori positive samples. Gastric intestinal metaplasia defined as the replacement of the surface, foveolar and glandular epithelium in the oxyntic or antral mucosa by the intestinal epithelium was absent in 89.5% of the samples.

Lymphoid follicles appear within a week after the onset of acute H. pylori infection, and are unusual on healthy/uninfected gastric mucosa [24]. Histopathological changes like foveolar hyperplasia and lymphoid follicles have shown, in the analyzed samples, a significant association with H. pylori. However, the evidence of ulcerated lesions in the antral region and fundic region did not support the idea that the presence of H. pylori represents significant development of either type of ulcerated lesion. The data showed that the lymphoid follicles were evidenced in 62% of the H. pylori positive gastric biopsy samples, evidenced the hypothesis of an important link between lymphoid follicles and infection [25]. The presence of foveolar hyperplasia in the gastric mucosa occurs in patients with normal histological presentation of gastric mucosa. It may, however, be a consequence of chronic inflammation and its association with H. pylori [26]. This finding had significant value (P < 0.001) in both the antrum and fundic regions.

It is known that H. pylori infection is characterized by a transient increase in acid secretion and hypochlorhydria, being a precursor for the development of active chronic gastritis, with a dense cellular infiltrate in the mucosa, which due to its persistence can cause serious damage to the gastric mucosa, which can progress to atrophic gastritis, glandular atrophy and intestinal metaplasia. The infection by the micro-organism is characterized by chronicity, which predisposes its participation in the pathogenesis of chronic gastritis, peptic ulcers (gastric and duodenal), adenocarcinoma, gastric lymphoma and recurrent abdominal pain.

Acknowledgments

The patologist Dra. Monica Lima de Araujo and the Laboratory of Pathological Anatomy Dra. Monica Araujo (LAPMA).

Financial Support

None.

Conflicts of Interest

None.


References▴Top 
  1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1(8390):1311-1315.
    doi
  2. Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology. 2008;134(1):306-323.
    doi pubmed
  3. Kao CY, Sheu BS, Wu JJ. Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesis. Biomed J. 2016;39(1):14-23.
    doi pubmed
  4. Bittencourt PFS, Rocha GA, Penna FJ, Queiroz DMM. Ulcera peptica gastroduodenal e infeccao pelo Helicobacter pylori na crianca e adolescente. Jornal De Pediatria. 2006;82(5):325-334.
    doi pubmed
  5. Marshall BJ. History of the discovery of C. pylori. In: Blaser MJ (Ed). Campylobacter Pylori in Gastritis and Peptic Ulcer Disease. New York: Igaku-Shoin. 1989; p. 7-23.
  6. Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of Helicobacter pylori infection. Helicobacter. 2014;19(Suppl 1):1-5.
    doi pubmed
  7. Nagy P, Johansson S, Molloy-Bland M. Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USA. Gut Pathog. 2016;8:8.
    doi pubmed
  8. Machida-Montani A, Sasazuki S, Inoue M, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, et al. Association of Helicobacter pylori infection and environmental factors in non-cardia gastric cancer in Japan. Gastric Cancer. 2004;7(1):46-53.
    doi pubmed
  9. Calvet X, Ramirez Lazaro MJ, Lehours P, Megraud F. Diagnosis and epidemiology of Helicobacter pylori infection. Helicobacter. 2013;18(Suppl 1):5-11.
    doi pubmed
  10. Robinson K, Argent RH, Atherton JC. The inflammatory and immune response to Helicobacter pylori infection. Best Pract Res Clin Gastroenterol. 2007;21(2):237-259.
    doi pubmed
  11. Stolte M, Meining A. The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment. Can J Gastroenterol. 2001;15(9):591-598.
    doi pubmed
  12. Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther. 2002;16(Suppl 1):3-15.
    doi pubmed
  13. Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev. 2000;22(2):283-297.
    doi pubmed
  14. Xu C, Yan M, Sun Y, Joo J, Wan X, Yu C, Wang Q, et al. Prevalence of Helicobacter pylori infection and its relation with body mass index in a Chinese population. Helicobacter. 2014;19(6):437-442.
    doi pubmed
  15. Fashner J, Gitu AC. Diagnosis and Treatment of Peptic Ulcer Disease and H. pylori Infection. Am Fam Physician. 2015;91(4):236-242.
    pubmed
  16. Wen S, Moss SF. Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Lett. 2009;282(1):1-8.
    doi pubmed
  17. Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2011;16(Suppl 1):1-9.
    doi pubmed
  18. Bedoya A, Garay J, Sanzon F, Bravo LE, Bravo JC, Correa H, Craver R, et al. Histopathology of gastritis in Helicobacter pylori-infected children from populations at high and low gastric cancer risk. Hum Pathol. 2003;34(3):206-213.
    doi pubmed
  19. Hagymasi K, Herszenyi L, Tulassay Z. From Chronic Gastritis to Gastric Cancer: The Role of Helicobacter pylori. Helicobacter Pylori: A Worldwide Perspective 2014, Oak Park, IL. 2014:316-335.
  20. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006;19(3):449-490.
    doi pubmed
  21. Zhang RG, Duan GC, Fan QT, Chen SY. Role of Helicobacter pylori infection in pathogenesis of gastric carcinoma. World J Gastrointest Pathophysiol. 2016;7(1):97-107.
    doi pubmed
  22. Alvares MMD, Marino M, Oliveira CA, Mendes CC, Costa ACF, Guerra J, Queiroz DMM, et al . Caracteristicas da gastrite cronica associada a Helicobacter pylori: aspectos topograficos, doencas associadas e correlacao com o status cagA. Jornal Brasileiro de Patologia e Medicina Laboratorial. 2006;42(1):51-59.
    doi
  23. Odze RD, Goldblum JR. Inflammatory disorders of the stomach. Surgical Pathology of the Gastrointestinal Tract, Liver, Biliary Tract, and Pancreas. Philadelphia. 2009:285.
  24. Hellstrom PM. Spotlight on gastroenterology - the Nobel Prize Laureates in Physiology or Medicine 2005: John Robin Warren and Barry James Marshall. Scand J Gastroenterol. 2005;40(12):1383-1385.
    doi pubmed
  25. Lee I. Critical pathogenic steps to high risk Helicobacter pylori gastritis and gastric carcinogenesis. World J Gastroenterol. 2014;20(21):6412-6419.
    doi pubmed
  26. Voutilainen M, Juhola M, Farkkila M, Sipponen P. Foveolar hyperplasia at the gastric cardia: prevalence and associations. J Clin Pathol. 2002;55(5):352-354.
    doi pubmed


This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Gastroenterology Research is published by Elmer Press Inc.

 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Gastroenterology Research, bimonthly, ISSN 1918-2805 (print), 1918-2813 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.

This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.gastrores.org   editorial contact: editor@gastrores.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.